{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:10:12Z","timestamp":1778523012473,"version":"3.51.4"},"reference-count":171,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.0901.18"],"award-info":[{"award-number":["G.0901.18"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004787","name":"The Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["OT14\/101"],"award-info":[{"award-number":["OT14\/101"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["CELSA\/18\/040"],"award-info":[{"award-number":["CELSA\/18\/040"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005930","name":"ASCRS Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005930","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.drudis.2019.03.020","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:37:45Z","timestamp":1553258265000},"page":"1092-1103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Therapeutic implications of novel peptides targeting ER\u2013mitochondria Ca2+-flux systems"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2497-9244","authenticated-orcid":false,"given":"Martijn","family":"Kerkhofs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Bultynck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Vervliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-4326","authenticated-orcid":false,"given":"Giovanni","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.03.020_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35036035","article-title":"The versatility and universality of calcium signalling","volume":"1","author":"Berridge","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/mol.116.105171","article-title":"Modulation of autophagy by calcium signalosome in human disease","volume":"90","author":"Filippi-Chiela","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","article-title":"Calcium signaling","volume":"131","author":"Clapham","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.03.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006767","article-title":"Ca2+ Signaling during mammalian fertilization: requirements, players, and adaptations","volume":"3","author":"Wakai","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0025","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm3412","article-title":"Mitochondria as sensors and regulators of calcium signalling","volume":"13","author":"Rizzuto","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ceca.2017.08.005","article-title":"The regulation of autophagy by calcium signals: do we have a consensus?","volume":"70","author":"Bootman","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2019.03.020_bib0035","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1073\/pnas.0906484106","article-title":"Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis","volume":"106","author":"Rimessi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.03.020_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/emboj\/18.1.96","article-title":"Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria","volume":"18","author":"Csordas","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2019.03.020_bib0045","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1126\/science.8235595","article-title":"Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria","volume":"262","author":"Rizzuto","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.drudis.2019.03.020_bib0050","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.bbamcr.2014.03.007","article-title":"Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival","volume":"1843","author":"Ivanova","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2019.03.020_bib0055","first-page":"3893","article-title":"Palmitoylation is the switch that assigns calnexin to quality control or ER Ca2+ signaling","volume":"126","author":"Lynes","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ceca.2017.06.007","article-title":"VDAC1 functions in Ca2+ homeostasis and cell life and death in health and disease","volume":"69","author":"Shoshan-Barmatz","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2019.03.020_bib0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ceca.2018.06.006","article-title":"Molecular regulation of MCU: implications in physiology and disease","volume":"74","author":"Nemani","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2019.03.020_bib0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1139\/cjpp-2014-0463","article-title":"The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA)","volume":"93","author":"Stammers","year":"2015","journal-title":"Canadian J. Physiol. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-94-007-2888-2_11","article-title":"Inositol 1,4,5-trisphosphate and its receptors","volume":"740","author":"Parys","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1152\/physrev.00035.2006","article-title":"Inositol trisphosphate receptor Ca2+ release channels","volume":"87","author":"Foskett","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drudis.2019.03.020_bib0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2013.03.012","article-title":"NCLX: the mitochondrial sodium calcium exchanger","volume":"59","author":"Boyman","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-981-10-4567-7_17","article-title":"Alterations in Ca2+ signalling via ER-mitochondria contact site remodelling in cancer","volume":"997","author":"Kerkhofs","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1083\/jcb.201401126","article-title":"Bridging the gap: membrane contact sites in signaling, metabolism, and organelle dynamics","volume":"205","author":"Prinz","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0105","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1083\/jcb.200608073","article-title":"Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels","volume":"175","author":"Szabadkai","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0110","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.15252\/embr.201541504","article-title":"FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria","volume":"17","author":"Doghman-Bouguerra","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drudis.2019.03.020_bib0115","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1091\/mbc.e08-07-0783","article-title":"Mitochondria are linked to calcium stores in striated muscle by developmentally regulated tethering structures","volume":"20","author":"Boncompagni","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.drudis.2019.03.020_bib0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2018.12.017","article-title":"Muscle activity prevents the uncoupling of mitochondria from Ca2+ release units induced by ageing and disuse","volume":"663","author":"Pietrangelo","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.drudis.2019.03.020_bib0125","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbamcr.2018.06.004","article-title":"Pathophysiological consequences of isoform-specific IP3 receptor mutations","volume":"1865","author":"Kerkhofs","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2174\/138945010791170888","article-title":"Chemosensitization of prostate cancer by modulating Bcl-2 family proteins","volume":"11","author":"Karnak","year":"2010","journal-title":"Curr. Drug Target."},{"key":"10.1016\/j.drudis.2019.03.020_bib0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/path.1711770206","article-title":"Expression of Bcl-2 oncogene protein is prevalent in small cell lung carcinomas","volume":"177","author":"Jiang","year":"1995","journal-title":"J. Pathol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1242\/jcs.031682","article-title":"Control of mitochondrial apoptosis by the Bcl-2 family","volume":"122","author":"Brunelle","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0145","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.bbamcr.2014.04.017","article-title":"A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum","volume":"1843","author":"Akl","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2019.03.020_bib0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature22798","article-title":"BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation","volume":"546","author":"Bononi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.03.020_bib0155","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature22965","article-title":"PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth","volume":"546","author":"Kuchay","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.03.020_bib0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2019.03.020_bib0165","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0170","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1200\/JCO.2011.37.0981","article-title":"Targeting the B-cell lymphoma\/leukemia 2 family in cancer","volume":"30","author":"Davids","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2017.03.006","article-title":"Multifaceted anticancer activity of BH3 mimetics: current evidence and future prospects","volume":"136","author":"Opydo-Chanek","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ceca.2017.05.014","article-title":"Bcl-2 inhibitors as anti-cancer therapeutics: the impact of and on calcium signaling","volume":"70","author":"Vervloessem","year":"2017","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2019.03.020_bib0185","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.cell.2016.05.080","article-title":"A BH3 mimetic for killing cancer cells","volume":"165","author":"Green","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.03.020_bib0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2019.03.020_bib0195","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1038\/onc.2016.31","article-title":"Bcl-2 proteins and calcium signaling: complexity beneath the surface","volume":"35","author":"Vervliet","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2019.03.020_bib0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2017.00075","article-title":"Modulation of Ca2+ signaling by anti-apoptotic B-cell lymphoma 2 proteins at the endoplasmic reticulum-mitochondrial interface","volume":"7","author":"Vervliet","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0205","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bbamcr.2008.10.015","article-title":"Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor","volume":"1793","author":"Rong","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2019.03.020_bib0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/cdd.2011.97","article-title":"Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl","volume":"19","author":"Monaco","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drudis.2019.03.020_bib0215","doi-asserted-by":"crossref","first-page":"14397","DOI":"10.1073\/pnas.0907555106","article-title":"The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor","volume":"106","author":"Rong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.03.020_bib0220","doi-asserted-by":"crossref","first-page":"E8844","DOI":"10.1073\/pnas.1721136115","article-title":"Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models","volume":"115","author":"Lee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.03.020_bib0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fnins.2018.00470","article-title":"Mitochondria and calcium regulation as basis of neurodegeneration associated with aging","volume":"12","author":"Muller","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molcel.2008.06.014","article-title":"Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2\u2019s inhibition of apoptotic calcium signals","volume":"31","author":"Rong","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2019.03.020_bib0235","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2010-09-307405","article-title":"Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction","volume":"117","author":"Zhong","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.03.020_bib0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41418-018-0142-3","article-title":"Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2\/IP3 receptor disruptor BIRD-2","volume":"26","author":"Bittremieux","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drudis.2019.03.020_bib0245","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.140","article-title":"IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2","volume":"4","author":"Akl","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2019.03.020_bib0250","doi-asserted-by":"crossref","first-page":"27388","DOI":"10.18632\/oncotarget.4489","article-title":"A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2","volume":"6","author":"Lavik","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2019.03.020_bib0255","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.355","article-title":"Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263","volume":"6","author":"Greenberg","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2019.03.020_bib0260","doi-asserted-by":"crossref","first-page":"111656","DOI":"10.18632\/oncotarget.22898","article-title":"Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax","volume":"8","author":"Vervloessem","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2019.03.020_bib0265","first-page":"809","article-title":"TAT fused IP3R derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release","volume":"41","author":"Xie","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.drudis.2019.03.020_bib0270","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbamcr.2018.07.020","article-title":"Targeting Bcl-2-IP3 receptor interaction to treat cancer: a novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones","volume":"1865","author":"Distelhorst","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-018-1297-z","article-title":"Recent advances in uncovering the mechanisms contributing to BIRD-2-induced cell death in B-cell cancer cells","volume":"10","author":"Kerkhofs","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2019.03.020_bib0280","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/0008-5472.CAN-17-0846","article-title":"Breast cancer targeting through inhibition of the endoplasmic reticulum-based apoptosis regulator Nrh\/BCL2L10","volume":"78","author":"Nougarede","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0285","doi-asserted-by":"crossref","first-page":"35291","DOI":"10.18632\/oncotarget.26250","article-title":"BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy","volume":"9","author":"Nougarede","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2019.03.020_bib0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biocel.2013.12.001","article-title":"Skeletal muscle excitation-contraction coupling: who are the dancing partners?","volume":"48","author":"Rebbeck","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0295","doi-asserted-by":"crossref","first-page":"22116","DOI":"10.1074\/jbc.270.38.22116","article-title":"Identification of calcium release-triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor","volume":"270","author":"el-Hayek","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0300","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bjp.0705981","article-title":"Functional implications of modifying RyR-activating peptides for membrane permeability","volume":"144","author":"Dulhunty","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0305","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/cmdc.201800366","article-title":"Exploiting peptidomimetics to synthesize compounds that activate ryanodine receptor calcium release channels","volume":"13","author":"Robinson","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2019.03.020_bib0310","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1085\/jgp.201511499","article-title":"Structure-function relationships of peptides forming the calcin family of ryanodine receptor ligands","volume":"147","author":"Xiao","year":"2016","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0315","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1085\/jgp.201611599","article-title":"Approaching ryanodine receptor therapeutics from the calcin angle","volume":"147","author":"Ramos-Franco","year":"2016","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0320","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1074\/jbc.274.12.7879","article-title":"Activation of ryanodine receptors by imperatoxin A and a peptide segment of the II-III loop of the dihydropyridine receptor","volume":"274","author":"Gurrola","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0325","first-page":"2782","article-title":"Bcl-2 binds to and inhibits ryanodine receptors","volume":"127","author":"Vervliet","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0330","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.1038\/srep09641","article-title":"Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain","volume":"5","author":"Vervliet","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2019.03.020_bib0335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2017.05.010","article-title":"Ca2+ signalling underlying pancreatitis","volume":"70","author":"Gerasimenko","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2019.03.020_bib0340","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1098\/rstb.2015.0423","article-title":"Calcium and adenosine triphosphate control of cellular pathology: asparaginase-induced pancreatitis elicited via protease-activated receptor 2","volume":"371","author":"Peng","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0345","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bjh.12016","article-title":"Asparaginase-associated pancreatitis in children","volume":"159","author":"Raja","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0350","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41420-018-0054-5","article-title":"BH4 domain peptides derived from Bcl-2\/Bcl-XL as novel tools against acute pancreatitis","volume":"4","author":"Vervliet","year":"2018","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drudis.2019.03.020_bib0355","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1172\/JCI94714","article-title":"Galactose protects against cell damage in mouse models of acute pancreatitis","volume":"128","author":"Peng","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2019.03.020_bib0360","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.tibs.2018.08.001","article-title":"Carbohydrate loading to combat acute pancreatitis","volume":"43","author":"Vervliet","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0365","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1042\/BST20140298","article-title":"Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein\u2013protein interactions for channel regulation","volume":"43","author":"Vervliet","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drudis.2019.03.020_bib0370","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pharmthera.2005.04.003","article-title":"Abnormal ryanodine receptor function in heart failure","volume":"107","author":"Yano","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2019.03.020_bib0375","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004242","article-title":"Calcium signaling in cardiac myocytes","volume":"3","author":"Fearnley","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0380","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaj1460","article-title":"Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides","volume":"9","author":"Anderson","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.drudis.2019.03.020_bib0385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.aad9873","article-title":"RNA. Small peptides control heart activity","volume":"351","author":"Payre","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.drudis.2019.03.020_bib0390","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1749-6632.2003.tb07231.x","article-title":"The regulation of SERCA-type pumps by phospholamban and sarcolipin","volume":"986","author":"MacLennan","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0395","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2012.12.005","article-title":"Decoy peptides targeted to protein phosphatase 1 inhibit dephosphorylation of phospholamban in cardiomyocytes","volume":"56","author":"Oh","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0400","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","article-title":"Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome","volume":"110","author":"Kranias","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0405","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.aad4076","article-title":"A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.drudis.2019.03.020_bib0410","doi-asserted-by":"crossref","first-page":"38319","DOI":"10.7554\/eLife.38319","article-title":"The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy","volume":"7","author":"Makarewich","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2019.03.020_bib0415","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nbd.2018.09.010","article-title":"Mitochondria and neuroprotection in stroke: cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics","volume":"121","author":"MacDougall","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2019.03.020_bib0420","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbabio.2006.07.002","article-title":"Therapeutic peptides: targeting the mitochondrion to modulate apoptosis","volume":"1757","author":"Jacotot","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2019.03.020_bib0425","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s13277-015-3719-1","article-title":"Mitochondrial targeted peptides for cancer therapy","volume":"36","author":"Farsinejad","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0430","first-page":"789","article-title":"A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity","volume":"126","author":"Qi","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0435","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/ars.2007.1892","article-title":"Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury","volume":"10","author":"Szeto","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.drudis.2019.03.020_bib0440","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2011-10-387399","article-title":"Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function","volume":"119","author":"Schoenwaelder","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.03.020_bib0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005646","article-title":"BH3 peptides induce mitochondrial fission and cell death independent of BAX\/BAK","volume":"4","author":"Shroff","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.03.020_bib0450","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bbamcr.2016.11.024","article-title":"The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca2+ signaling","volume":"1864","author":"Vervloessem","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0455","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fchem.2018.00108","article-title":"VDAC1 as pharmacological target in cancer and neurodegeneration: focus on its role in apoptosis","volume":"6","author":"Magri","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0460","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbamcr.2013.03.017","article-title":"The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis","volume":"1833","author":"Keinan","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2019.03.020_bib0465","doi-asserted-by":"crossref","first-page":"24986","DOI":"10.1074\/jbc.M116.744284","article-title":"Novel compounds targeting the mitochondrial protein VDAC1 inhibit apoptosis and protect against mitochondrial dysfunction","volume":"291","author":"Ben-Hail","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0470","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1126\/science.1161302","article-title":"Solution structure of the integral human membrane protein VDAC-1 in detergent micelles","volume":"321","author":"Hiller","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.drudis.2019.03.020_bib0475","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.316","article-title":"VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia","volume":"4","author":"Prezma","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2019.03.020_bib0480","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.419","article-title":"Mcl-1 promotes lung cancer cell migration by directly interacting with VDAC to increase mitochondrial Ca2+ uptake and reactive oxygen species generation","volume":"5","author":"Huang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2019.03.020_bib0485","doi-asserted-by":"crossref","first-page":"19870","DOI":"10.1074\/jbc.M112.448290","article-title":"An interaction between Bcl-xL and the voltage-dependent anion channel (VDAC) promotes mitochondrial Ca2+ uptake","volume":"288","author":"Huang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0490","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1074\/jbc.M803614200","article-title":"Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity","volume":"284","author":"Arzoine","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0495","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/1878-0261.12313","article-title":"Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy","volume":"12","author":"Shteinfer-Kuzmine","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0500","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2008.08.031","article-title":"Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide","volume":"274","author":"Oh","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drudis.2019.03.020_bib0505","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbagen.2011.07.016","article-title":"The transferrin receptor and the targeted delivery of therapeutic agents against cancer","volume":"1820","author":"Daniels","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2019.03.020_bib0510","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.neo.2018.02.012","article-title":"Targeting liver cancer and associated pathologies in mice with a mitochondrial VDAC1-based peptide","volume":"20","author":"Pittala","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.drudis.2019.03.020_bib0515","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/092986712798992110","article-title":"Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy","volume":"19","author":"Shoshan-Barmatz","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0520","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.97.7.3100","article-title":"BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death","volume":"97","author":"Shimizu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.03.020_bib0525","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1074\/jbc.M114.622514","article-title":"The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria","volume":"290","author":"Monaco","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0530","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fphys.2018.00755","article-title":"ER-mitochondria microdomains in cardiac ischemia-reperfusion injury: a fresh perspective","volume":"9","author":"Zhou","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0535","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbrc.2016.07.122","article-title":"Mitochondrial Ca2+ handling in Huntington\u2019s and Alzheimer\u2019s diseases - role of ER-mitochondria crosstalk","volume":"483","author":"Naia","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2019.03.020_bib0540","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/dmm.028738","article-title":"The role of Ca2+ signaling in Parkinson\u2019s disease","volume":"10","author":"Zaichick","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.drudis.2019.03.020_bib0545","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fncel.2014.00184","article-title":"Dysfunctional mitochondrial Ca2+ handling in mutant SOD1 mouse models of fALS: integration of findings from motor neuron somata and motor terminals","volume":"8","author":"Barrett","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0550","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/hmg\/ddr513","article-title":"The BH4 domain of Bcl-XL rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals","volume":"21","author":"Martorana","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2019.03.020_bib0555","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2011.07.037","article-title":"Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo","volume":"156","author":"Boisguerin","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.03.020_bib0560","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2004.08.116","article-title":"Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets","volume":"323","author":"Klein","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2019.03.020_bib0565","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/hmg\/ddr513","article-title":"The BH4 domain of Bcl-XL rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals","volume":"21","author":"Martorana","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2019.03.020_bib0570","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejcts.2004.09.025","article-title":"BH4 peptide derivative from Bcl-xL attenuates ischemia\/reperfusion injury thorough anti-apoptotic mechanism in rat hearts","volume":"27","author":"Ono","year":"2005","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.drudis.2019.03.020_bib0575","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1038\/sj.onc.1207180","article-title":"BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo","volume":"22","author":"Sugioka","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2019.03.020_bib0580","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/ddt576","article-title":"Apoptotic cell death and altered calcium homeostasis caused by frataxin depletion in dorsal root ganglia neurons can be prevented by BH4 domain of Bcl-xL protein","volume":"23","author":"Mincheva-Tasheva","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2019.03.020_bib0585","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/BSR20110033","article-title":"HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells","volume":"32","author":"Yu","year":"2012","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.drudis.2019.03.020_bib0590","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/carcin\/bgx016","article-title":"Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain","volume":"38","author":"Gabellini","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.drudis.2019.03.020_bib0595","doi-asserted-by":"crossref","first-page":"34802","DOI":"10.1038\/srep34802","article-title":"Hexokinase I N-terminal based peptide prevents the VDAC1-SOD1 G93A interaction and re-establishes ALS cell viability","volume":"6","author":"Magri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2019.03.020_bib0600","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.2174\/0929867324666170601073920","article-title":"Interactions of VDAC with proteins involved in neurodegenerative aggregation: an opportunity for advancement on therapeutic molecules","volume":"24","author":"Magri","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0605","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1096\/fj.201601173R","article-title":"Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells","volume":"31","author":"Woldetsadik","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2019.03.020_bib0610","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.2174\/0929867324666170530074039","article-title":"Anti-cancer compounds targeted to VDAC: potential and perspectives","volume":"24","author":"Reina","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0615","doi-asserted-by":"crossref","first-page":"13907","DOI":"10.1039\/C5NR00980D","article-title":"Mitochondria-acting hexokinase II peptides carried by short-length carbon nanotubes with increased cellular uptake, endosomal evasion, and enhanced bioactivity against cancer cells","volume":"7","author":"Yoong","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2019.03.020_bib0620","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/cb400821p","article-title":"Molecular vehicles for mitochondrial chemical biology and drug delivery","volume":"9","author":"Rin Jean","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0625","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chembiol.2008.03.015","article-title":"Mitochondria-penetrating peptides","volume":"15","author":"Horton","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0630","doi-asserted-by":"crossref","first-page":"29927","DOI":"10.18632\/oncotarget.9179","article-title":"A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells","volume":"7","author":"Gaudio","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2019.03.020_bib0635","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.biopha.2009.09.024","article-title":"B-type natriuretic peptide protects cardiomyocytes at reperfusion via mitochondrial calcium uniporter","volume":"64","author":"Sun","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drudis.2019.03.020_bib0640","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.jacc.2012.07.056","article-title":"Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide","volume":"60","author":"Chen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0645","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1586\/14779072.2015.1051034","article-title":"Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials","volume":"13","author":"Fajardo","year":"2015","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.drudis.2019.03.020_bib0650","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008545","article-title":"Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials","volume":"6","author":"Gong","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.drudis.2019.03.020_bib0655","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yjmcc.2016.12.007","article-title":"CaMKII is a nodal signal for multiple programmed cell death pathways in heart","volume":"103","author":"Feng","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0660","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1074\/jbc.M611507200","article-title":"Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis","volume":"282","author":"Zhu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0665","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00395-016-0581-2","article-title":"Inducible cardiomyocyte-specific deletion of CaM kinase II protects from pressure overload-induced heart failure","volume":"111","author":"Kreusser","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0670","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature11444","article-title":"CaMKII determines mitochondrial stress responses in heart","volume":"491","author":"Joiner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.03.020_bib0675","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1172\/JCI38857","article-title":"Calcium\/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways","volume":"119","author":"Timmins","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2019.03.020_bib0680","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00726-018-2644-1","article-title":"Mitochondrial targeting domain of NOXA causes necrosis in apoptosis-resistant tumor cells","volume":"50","author":"Nguyen","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.drudis.2019.03.020_bib0685","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fphar.2014.00067","article-title":"CaMKII and stress mix it up in mitochondria","volume":"5","author":"Joiner","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0690","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00395-017-0618-1","article-title":"Mitochondrial Cx43 hemichannels contribute to mitochondrial calcium entry and cell death in the heart","volume":"112","author":"Gadicherla","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0695","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fphar.2014.00021","article-title":"CaMKII inhibitors: from research tools to therapeutic agents","volume":"5","author":"Pellicena","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0700","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1006\/bbrc.1995.2040","article-title":"A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem","volume":"212","author":"Ishida","year":"1995","journal-title":"Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2019.03.020_bib0705","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1113\/jphysiol.1995.sp020944","article-title":"A non-selective cation current activated via the multifunctional Ca2+-calmodulin-dependent protein kinase in human epithelial cells","volume":"488","author":"Braun","year":"1995","journal-title":"J. Physiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0710","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1073\/pnas.95.18.10890","article-title":"Characterization of a calmodulin kinase II inhibitor protein in brain","volume":"95","author":"Chang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.03.020_bib0715","first-page":"66","article-title":"Inhibition of cardiac CaMKII to cure heart failure: step by step towards translation? Basic Res","volume":"111","author":"Cuello","year":"2016","journal-title":"Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0720","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature13626","article-title":"Mitochondrial Ca2+ uniporter and CaMKII in heart","volume":"513","author":"Fieni","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.03.020_bib0725","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceca.2018.05.003","article-title":"The still uncertain identity of the channel-forming unit(s) of the mitochondrial permeability transition pore","volume":"73","author":"Baines","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2019.03.020_bib0730","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1172\/JCI43171","article-title":"Cyclophilin D controls mitochondrial pore-dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice","volume":"120","author":"Elrod","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2019.03.020_bib0735","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCRESAHA.115.308093","article-title":"Individual cardiac mitochondria undergo rare transient permeability transition pore openings","volume":"118","author":"Lu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0740","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ceca.2017.05.004","article-title":"Calcium and regulation of the mitochondrial permeability transition","volume":"70","author":"Giorgio","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.drudis.2019.03.020_bib0745","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.113.001225","article-title":"Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury","volume":"128","author":"Paillard","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2019.03.020_bib0750","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.2337\/db13-1751","article-title":"Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance","volume":"63","author":"Tubbs","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2019.03.020_bib0755","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00125-015-3829-8","article-title":"Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance","volume":"59","author":"Rieusset","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2019.03.020_bib0760","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1124\/jpet.109.153213","article-title":"Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases","volume":"330","author":"Javadov","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2019.03.020_bib0765","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","article-title":"Effect of cyclosporine on reperfusion injury in acute myocardial infarction","volume":"359","author":"Piot","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2019.03.020_bib0770","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","article-title":"Cyclosporine before PCI in patients with acute myocardial infarction","volume":"373","author":"Cung","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2019.03.020_bib0775","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2015.10.081","article-title":"Cyclosporine A in reperfused myocardial infarction: the multicenter, controlled, open-label CYCLE trial","volume":"67","author":"Ottani","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0780","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fchem.2018.00073","article-title":"Targeting endoplasmic reticulum and\/or mitochondrial Ca2+ fluxes as therapeutic strategy for HCV infection","volume":"6","author":"Scrima","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0785","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.antiviral.2011.01.003","article-title":"Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy","volume":"89","author":"Lawitz","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0790","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.27960","article-title":"Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2019.03.020_bib0795","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1158\/0008-5472.CAN-09-0349","article-title":"The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with calcium release","volume":"69","author":"Seo","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0800","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/psc.2525","article-title":"Minimal killing unit of the mitochondrial targeting domain of Noxa","volume":"19","author":"Kim","year":"2013","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0805","doi-asserted-by":"crossref","first-page":"C398","DOI":"10.1152\/ajpcell.00283.2016","article-title":"Mitochondrial connexin40 regulates mitochondrial calcium uptake in coronary endothelial cells","volume":"312","author":"Guo","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0810","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1074\/jbc.M111.299610","article-title":"Connexin 43 hemichannels contribute to cytoplasmic Ca2+ oscillations by providing a bimodal Ca2+-dependent Ca2+ entry pathway","volume":"287","author":"De Bock","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0815","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cvr\/cvu066","article-title":"The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent","volume":"103","author":"Srisakuldee","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.drudis.2019.03.020_bib0820","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00018-017-2722-7","article-title":"The SH3-binding domain of Cx43 participates in loop\/tail interactions critical for Cx43-hemichannel activity","volume":"75","author":"Iyyathurai","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0825","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00395-012-0309-x","article-title":"Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia\/reperfusion injury","volume":"108","author":"Wang","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.drudis.2019.03.020_bib0830","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1096\/fj.09-153007","article-title":"Intramolecular loop\/tail interactions are essential for connexin 43-hemichannel activity","volume":"24","author":"Ponsaerts","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2019.03.020_bib0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181748","article-title":"THPdb: database of FDA-approved peptide and protein therapeutics","volume":"12","author":"Usmani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.03.020_bib0840","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2019.03.020_bib0845","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.drudis.2017.10.016","article-title":"Interfering peptides targeting protein\u2013protein interactions: the next generation of drugs?","volume":"23","author":"Bruzzoni-Giovanelli","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2019.03.020_bib0850","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.tips.2016.05.008","article-title":"Systematic targeting of protein\u2013protein interactions","volume":"37","author":"Modell","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drudis.2019.03.020_bib0855","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41419-018-0424-1","article-title":"Mitochondria-associated membranes (MAMs) and pathologies","volume":"9","author":"Pinton","year":"2018","journal-title":"Cell Death Dis."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461830480X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461830480X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:21:12Z","timestamp":1778520072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964461830480X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":171,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S135964461830480X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.020","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic implications of novel peptides targeting ER\u2013mitochondria Ca2+-flux systems","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}